Current issues in adjuvant chemotherapy for resected, stage IB non-small-cell lung cancer

By Borghaei Hossein   Mehra Ranee   Simon George  

Future Oncology, Vol. 5, Iss. 1, 2009-02 ,pp. : 19-22

Future Medicine

Access to resources Recommend Favorite

Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA–IIIA non-small-cell lung cancer

By Kawamura Masafumi   Eguchi Keisuke   Izumi Yotaro   Yamato Yasushi   Koike Teruaki   Sakaguchi Hirozo   Hada Enjo   Kobayashi Koichi  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 4, 2007-09 ,pp. : 495-501

Springer Publishing Company

Access to resources Recommend Favorite

Locoregional recurrence of early-stage surgically resected non-small-cell lung cancer: the importance of close follow-up and consistent definitions

By Varlotto J.   Recht A.   Medford-Davis L. N.   Flickinger J. C.   DeCamp M.  

Annals of Oncology, Vol. 24, Iss. 6, 2013-06 ,pp. : 1711-1712

Oxford University Press

Access to resources Recommend Favorite

A Gene Signature Combining the Tissue Expression of Three Angiogenic Factors is a Prognostic Marker in Early-stage Non-small Cell Lung Cancer

By Sanmartín Elena   Sirera Rafael   Usó Marta   Blasco Ana   Gallach Sandra   Figueroa Santiago   Martínez Nieves   Hernando Cristina   Honguero Antonio   Martorell Miguel   Guijarro Ricardo   Rosell Rafael   Jantus-Lewintre Eloisa   Camps Carlos  

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 612-620

Springer Publishing Company

Access to resources Recommend Favorite

Surveillance of resected non-small cell lung cancer

By López-González A.  

Clinical and Translational Oncology, Vol. 14, Iss. 10, 2012-10 ,pp. : 721-725

Springer Publishing Company

Access to resources Recommend Favorite